These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34413183)

  • 1. Personalised therapy during preconception and gestation in SLE: usefulness of 6-mercaptopurine metabolite levelswith azathioprine.
    Lambert-Fliszar F; Bernatsky S; Kalache F; Grenier LP; Pineau CA; Vinet E
    Lupus Sci Med; 2021 Aug; 8(1):. PubMed ID: 34413183
    [No Abstract]   [Full Text] [Related]  

  • 2. Azathioprine therapy for patients with systemic lupus erythematosus.
    Abu-Shakra M; Shoenfeld Y
    Lupus; 2001; 10(3):152-3. PubMed ID: 11315344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutics. XI. Immunosuppressive drugs.
    Ashton H; Beveridge GW; Stevenson CJ
    Br J Dermatol; 1970 Aug; 83(2):326-30. PubMed ID: 4916789
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug alternatives in therapy of neuropsychiatric systemic lupus erythematosus (NPSLE)].
    Harten P
    Med Klin (Munich); 2003 Jun; 98(6):344; author reply 344-5. PubMed ID: 12877108
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunosuppressive therapy in the treatment of autoimmune diseases.
    Miescher PA; Beris P
    Springer Semin Immunopathol; 1984; 7(1):69-90. PubMed ID: 6377542
    [No Abstract]   [Full Text] [Related]  

  • 6. An unusual case of systemic lupus erythematosus, lupus nephritis, and transient monoclonal gammopathy.
    Strobel ES; Fritschka E; Schmitt-Gräff A; Peter HH
    Rheumatol Int; 2000; 19(6):235-41. PubMed ID: 11063295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transformation of lymphocytes during immunosuppressive therapy in lupus erythematosus visceralis].
    Heine KM; Klatt R; Stobbe H; Apostoloff E; Jendrusch C
    Z Gesamte Inn Med; 1969 May; 24(10):152-4. PubMed ID: 5812420
    [No Abstract]   [Full Text] [Related]  

  • 8. [Combined immunosuppressive treatment of systemic lupus erythematosus].
    Pluzańska A; Dmochowska M; Orlowski Z; Pawlowski J; Krauze-Jaworska H; Krykowski E; Zebrowski A
    Pol Arch Med Wewn; 1974 Sep; 52(3):275-81. PubMed ID: 4418141
    [No Abstract]   [Full Text] [Related]  

  • 9. Research and therapeutics-traditional and emerging therapies in systemic lupus erythematosus.
    Davis LS; Reimold AM
    Rheumatology (Oxford); 2017 Apr; 56(suppl_1):i100-i113. PubMed ID: 28375452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic lupus erythematosus and pregnancy: the challenge of improving antenatal care and outcomes.
    Pastore DEA; Costa ML; Surita FG
    Lupus; 2019 Oct; 28(12):1417-1426. PubMed ID: 31551036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive drug therapy of systemic lupus erythematosus.
    Fox DA; McCune WJ
    Rheum Dis Clin North Am; 1994 Feb; 20(1):265-99. PubMed ID: 8153402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lymphocyte transformation during immunosuppressive therapy of lupus erythematosus visceralis].
    Heine KM; Klatt R; Stobbe H; Apostoloff E; Jendrusch C
    Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:152-4. PubMed ID: 5402572
    [No Abstract]   [Full Text] [Related]  

  • 13. [Results of immunosuppressive treatment of visceral lupus erythematosus].
    Japa J; Kardaszewicz E
    Pol Tyg Lek; 1969 Oct; 24(40):1534-6. PubMed ID: 5365671
    [No Abstract]   [Full Text] [Related]  

  • 14. Azathioprine treatment and thiopurine metabolism in rheumatic diseases. Introduction and first results of investigation.
    Stolk JN; Boerbooms AM; De Abreu RA; van de Putte LB
    Adv Exp Med Biol; 1998; 431():487-93. PubMed ID: 9598116
    [No Abstract]   [Full Text] [Related]  

  • 15. [Psoriasis and systemic lupus erythematosus: a rare association with specific therapeutic problems].
    Astudillo L; Sailler L; Carreiro M; Dahan S; Ollier S; Arlet P
    Ann Med Interne (Paris); 2003 Feb; 154(1):3-6. PubMed ID: 12746653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aplastic anemia secondary to azathioprine in systemic lupus erythematosus: report of a case with normal thiopurine S-methyltransferase enzyme activity and review of the literature.
    Yeter KC; Afkhami M; Brynes RK; Quismorio FP
    Lupus; 2013 Dec; 22(14):1526-8. PubMed ID: 24029750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indicators of clinical response to treatment with six-mercaptopurine or azathioprine in patients with inflammatory bowel disease.
    Achkar JP; Stevens T; Easley K; Brzezinski A; Seidner D; Lashner B
    Inflamm Bowel Dis; 2004 Jul; 10(4):339-45. PubMed ID: 15475740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experts Opinion on the Practical Use of Azathioprine and 6-Mercaptopurine in Inflammatory Bowel Disease.
    Mottet C; Schoepfer AM; Juillerat P; Cosnes J; Froehlich F; Kessler-Brondolo V; Seibold F; Rogler G; Vavricka SR; Michetti P
    Inflamm Bowel Dis; 2016 Nov; 22(11):2733-2747. PubMed ID: 27760078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azathioprine during pregnancy in systemic lupus erythematosus patients is not associated with poor fetal outcome.
    Saavedra MÁ; Sánchez A; Morales S; Ángeles U; Jara LJ
    Clin Rheumatol; 2015 Jul; 34(7):1211-6. PubMed ID: 26050103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab treatment in a child with rosai-dorfman disease and systemic lupus erythematosus.
    Alqanatish JT; Houghton K; Bond M; Senger C; Tucker LB
    J Rheumatol; 2010 Aug; 37(8):1783-4. PubMed ID: 20675857
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.